✦ LIBER ✦

Involvement of vacuolar H+-ATPase in incorporation of risedronate into osteoclasts

✍ Scribed by M Takami; K Suda; T Sahara; K Itoh; K Nagai; T Sasaki; N Udagawa; N Takahashi

Book ID: 117807811
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 583 KB
Volume: 32
Category: Article
ISSN: 8756-3282
DOI: 10.1016/s8756-3282(03)00024-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Characterization of vacuolar-ATPase and

Characterization of vacuolar-ATPase and selective inhibition of vacuolar-H(+)-ATPase in osteoclasts

✍ GuanFeng Yao; HaoTian Feng; YanLing Cai; WeiLi Qi; KangMei Kong 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 264 KB

Characterization of the osteoclast vacuo

Characterization of the osteoclast vacuolar H+-ATPase B-subunit

✍ Marcjanna Bartkiewicz; Natividad Hernando; Sakamuri V. Reddy; G.David Roodman; R 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 834 KB

A pharmacological assessment of the mamm

A pharmacological assessment of the mammalian osteoclast vacuolar H+-ATPase

✍ Hall, Tony J.; Schaueblin, Michelle 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 398 KB

Electrogenicity of Vacuolar H+-ATPases a

Electrogenicity of Vacuolar H+-ATPases at the Plasma Membrane of Osteoclasts

✍ Sakai, Hiromu; Moriura, Yoshie; Kawawaki, Junko; Kuno, Miyuki 📂 Article 📅 2012 🏛 Biophysical Society 🌐 English ⚖ 47 KB

Specific Inhibitors of Vacuolar H+-ATPas

Specific Inhibitors of Vacuolar H+-ATPase Trigger Apoptotic Cell Death of Osteoclasts

✍ Nobuo Okahashi; Ichiro Nakamura; Eijiro Jimi; Masanori Koide; Tatsuo Suda; Tatsu 📂 Article 📅 1997 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 627 KB

The bisphosphonate tiludronate is a pote

The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H+-ATPase

✍ Pe'Er David; Hieu Nguyen; Alain Barbier; Roland Baron 📂 Article 📅 1996 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 996 KB

## Abstract Although bisphosphonates have been shown to be potent inhibitors of osteoclast‐mediated bone resorption in vivo and in vitro and are used as therapeutic agents in hyper‐resorptive bone diseases such as Paget disease or hypercalcemia of malignancy, their exact biochemical target(s) and m